Cryo-Save Group N.V. - board change
Cryo-Save Group N.V. (Euronext: CRYO, 'Cryo-Save', or 'the Group'), the leading international family stem cell bank and the largest bank in Europe, announces that Marc Waeterschoot, co-founder and Executive Director of Cryo-Save, will resign as Executive Director of the Group after 12 years of active involvement. He will step down from his Executive position on 30 September 2012.
Mr. Waeterschoot will remain a shareholder in the Company, and will hold a position as Non-Executive Director in the Board of Directors.
Johan Goossens, Chairman Cryo-Save:
"Marc's vision and leadership has shaped Cryo-Save into the successful company it is today. We are very grateful for his continuous contributions and support. I am particularly pleased that Marc accepted to continue to serve as a Non-Executive Director; his knowledge of the stem cell industry and insights remain of great value to Cryo-Save."
Enquiries:
| Cryo-Save Group | + 31 (0) 575 548 998 |
| Arnoud van Tulder, Chief Executive Officer | |
| Daniel Stewart & Company plc (UK) | + 44 (0) 20 7776 6550 |
| Martin Lampshire | |
| College Hill (UK) | + 44 (0) 20 7457 2020 |
| Rozi Morris/ Adrian Duffield |
Free footage is available on www.videobankonline.com.
About Cryo-Save (www.cryo-save.com/group)
Cryo-Save, the leading international family stem cell bank and largest bank in Europe, stores more than 222,000 samples from cord blood and umbilical cord tissue for newborns and adipose tissue for adults. These stem cells can mean the difference between life and death in the case of future threats to the health of the donors.
There are already many diseases treatable by the use of stem cells, and the number of treatments will only increase. Driven by its international business strategy, Cryo-Save is now represented in over 40 countries on three continents, with ultra-modern processing and storage facilities in Belgium, Germany, Dubai, India and South Africa.
